From the Lab to the Clinic, Stanford Women are Making History

They are mentors, voices for diversity and inclusion, grant recipients, innovators, researchers and more. This March, we are excited to celebrate and honor the accomplishments, contributions and leadership of the many women at the Stanford Department of Medicine. From cancer therapies to population health to primary care, their work is instrumental in improving the health and wellness of individuals in our local communities and around the globe.

In honor of Women’s History Month, we are sharing their inspiring stories!

 


Women Making History

Tamara Dunn

Clinical assistant professor Tamara Dunn, MD, is a hematologist, artist, singer, American Society of Hematology ambassador, and a voice for diversity and inclusion.

Christina Curtis

Christina Curtis, MD, assistant professor of oncology and genetics, is using her NIH Pioneer Award to create computational and statistical techniques that will help clinicians anticipate tumor behavior  and progression over time.

Charlotte Jacobs

Early in her academic career, Charlotte Jacobs, MD, professor emerita of medicine, focused her research and writing on solid cancerous tumors. When she later became associate dean, she wrote about medical education and clinical training. Simmering below these professional writing endeavors, however, was a desire to also pursue a different kind of writing.

Fatima Rodriguez

The influences in Fatima Rodriguez’s life began early. A child of immigrants, she was raised by a single mother who developed rheumatic heart disease. Additional influences came her way at Harvard Medical School. Today, Rodriguez is a new assistant professor in the cardiovascular division with a particular interest in health disparities and improving cardiovascular risk prediction for understudied populations.

Karina Delgado-Carrasco

As program manager of the Medicine Residency, Karina Delgado-Carrasco is surrounded by residents, from first-years looking for mentorship guidance, to third-years planning the next steps in their career. It’s a role she’s handled with aplomb – elevating the program with her abilities and dedication while spearheading new initiatives focused on residency wellbeing.

Wendy Caceres

Just a few years out of her own residency in internal medicine, clinical assistant professor of primary care and population health Wendy Caceres, MD, is enjoying several roles as clinician, mentor to medical students and residents, and educator.

Marcella Alsan

Marcella Alsan, MD, PhD, an associate professor of medicine and the only infectious-disease trained economist in the United States, is committed to understanding the relationship between health and socioeconomic disparities.

Catherine Blish

Chan Zuckerberg Biohub Initiative recipient Catherine Blish, MD, PhD, is exploring how the innate immune system copes with and recognizes the diversity of viruses it encounters. The hope, Blish, an associate professor of infectious diseases, says, is to use these common recognition patterns to come up with new approaches to vaccination.

Neera Ahuja

Neera Ahuja, MD, clinical professor of medicine, leads Stanford’s Division of Hospital Medicine and the Hospitalist Program. Known for her “outstanding clinical skils and teaching abilities,” Ahuja is committed to furthering the development of clinical research and hospitalists.

Georgette Stratos

For over 30 years, Georgette Stratos, PhD, senior research scholar of primary care and population health, has been teaching physician-teachers how to teach better and, importantly, how to train their colleagues back home to do the same.

Sharon Hunt

In 1968, when Shumway performed the first heart transplant in the US, Sharon Hunt, MD, professor of cardiovascular medicine, was one of seven women attending Stanford Medical School, and was working in a cardiology lab. Over the past 20 years, she has cared for more than 1500 heart transplant patients, and trained and more than 40 fellows.

Crystal Mackall

Crystal Mackall, MD, professor of bone and marrow transplantation, is joining forces with doctors and researchers who have a wide range of expertise to make Stanford a leading institution for cell therapies to treat cancer.